Renal insufficiency Trials in Boston, United States
Conditions / Renal insufficiency / Boston, United States
Renal insufficiency has been the subject of sustained clinical investigation across multiple research sites.
13 total trials for this combination
Showing top 10 of 13 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00709865 | Study to Assess the Safety and Tolerability of IV Tonapofylline in Subjects With Acute Decompensated Heart Failure (ADHF) and Renal Insufficiency | COMPLETED | PHASE3 |
| NCT01524276 | Product Surveillance Registry | RECRUITING | — |
| NCT00744939 | Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist | COMPLETED | — |
| NCT00338455 | Natrecor (Nesiritide) in Transplant-Eligible Management of Congestive Heart Failure-TMAC | TERMINATED | PHASE2 |
| NCT06001827 | SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study | RECRUITING | NA |
| NCT00159614 | Effect of KW-3902IV in Combination With IV Furosemide on Renal Function in Subjects With CHF and Renal Impairment | COMPLETED | PHASE2 |
| NCT01105923 | Study of an Intervention to Improve Problem List Accuracy and Use | UNKNOWN | NA |
| NCT03815175 | XIENCE 28 USA Study | COMPLETED | NA |
| NCT00770081 | Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study) | COMPLETED | PHASE3 |
| NCT00745316 | Oral Tonapofylline (BG9928) in Patients With Heart Failure and Renal Insufficiency | TERMINATED | PHASE2 |